Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncotherapy Cancer Center
Kawasaki City, Kanagawa Prefecture, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
OncoTherapy Science develops anti-cancer medicines using genomics-driven approaches to identify novel targets highly expressed in tumors. Its pipeline includes small molecules, peptide vaccines, and antibody drugs targeting various tumor-associated proteins. Several candidates have reached clinical trials up to Phase 3. The company collaborates closely with academic institutions such as the University of Tokyo.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeSynthetic peptide vaccineTherapeutic vaccineSynthetic peptideInactivated vaccine
- Industry
- Biotech
02
Partnerships
Institute of Medical Science at University of TokyoTheragen Bio Co., Ltd.MBL Co., Ltd.
Beyond the preview
Go deeper on Oncotherapy Cancer Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oncotherapy Cancer Center.